Abstract:The innate immune system is an evolutionarily conserved system that senses and defends against infection and irritation. Innate immune signaling is a complex cascade that quickly recognizes infectious threats through multiple germline-encoded cell surface or cytoplasmic receptors and transmits signals for the deployment of proper countermeasures through adaptors, kinases, and transcription factors, resulting in the production of cytokines. As the first response of the innate immune system to pathogenic signals, inflammatory responses must be rapid and specific to establish a physical barrier against the spread of infection and must subsequently be terminated once the pathogens have been cleared. Long-lasting and low-grade chronic inflammation is a distinguishing feature of type 2 diabetes and cardiovascular diseases, which are currently major public health problems. Cardiometabolic stress-induced inflammatory responses activate innate immune signaling, which directly contributes to the development of cardiometabolic diseases. Additionally, although the innate immune elements are highly conserved in higher-order jawed vertebrates, lower-grade jawless vertebrates lack several transcription factors and inflammatory cytokine genes downstream of the Toll-like receptors (TLRs) and retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) pathways, suggesting that innate immune signaling components may additionally function in an immune-independent way. Notably, recent studies from our group and others have revealed that innate immune signaling can function as a vital regulator of cardiometabolic homeostasis independent of its immune function. Therefore, further investigation of innate immune signaling in cardiometabolic systems may facilitate the discovery of new strategies to manage the initiation and progression of cardiometabolic disorders, leading to better treatments for these diseases. In this review, we summarize the current progress in innate immune signaling studies and the regulatory function of innate immunity in cardiometabolic diseases. Notably, we highlight the immune-independent effects of innate immune signaling components on the development of cardiometabolic disorders.

DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects

Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease

Cellular functions of cGAS-STING signaling

DNA-sensing pathways in health, autoinflammatory and autoimmune diseases

Cytosolic DNA sensors in neurodegenerative diseases: from physiological defenders to pathological culprits

Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy

Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.

DNA Sensors, Crucial Receptors to Resist Pathogens, Are Deregulated in Colorectal Cancer and Associated with Initiation and Progression of the Disease.

Targeting DNA Damage Response in Cardiovascular Diseases: from Pathophysiology to Therapeutic Implications

DNA sensing by the cGAS–STING pathway in health and disease

The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks.

The role of the cGAS-STING pathway in metabolic diseases

Sensing Self and Non-Self DNA by Innate Immune Receptors and Their Signaling Pathways

Post-translational modification control of viral DNA sensors and innate immune signaling

Innate Immune Response to Cytoplasmic DNA: Mechanisms and Diseases.

The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives

Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways